anti-VPAC1 antibodies (Catholic University of Leuven/ThromboGenics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-VPAC1 antibodies (Catholic University of Leuven/ThromboGenics)
Drug Alias Name23A11
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionVasoactive intestinal polypeptide receptor 1 modulators
TargetsVasoactive intestinal polypeptide receptor 1
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKu Leuven
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxurion Nv
Active IndicationsN/A
Inactive IndicationsThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A